Philadelphia Trust Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,600	Closed	-$661K	–	250
2021 Q2	$661K	Sell	3,600 -50	-1%	-$9.18K	0.05%	161
2021 Q1	$558K	Sell	3,650 -150	-4%	-$22.9K	0.04%	163
2020 Q4	$594K	Buy	3,800 +300	+9%	+$46.9K	0.05%	143
2020 Q3	$401K	Hold	3,500	–	–	0.04%	154
2020 Q2	$393K	Hold	3,500	–	–	0.04%	138
2020 Q1	$314K	Hold	3,500	–	–	0.04%	136
2019 Q4	$379K	Hold	3,500	–	–	0.03%	169
2019 Q3	$343K	Hold	3,500	–	–	0.03%	175
2019 Q2	$458K	Hold	3,500	–	–	0.04%	165
2019 Q1	$473K	Hold	3,500	–	–	0.04%	163
2018 Q4	$341K	Hold	3,500	–	–	0.04%	148
2018 Q3	$487K	Hold	3,500	–	–	0.04%	151
2018 Q2	$435K	Hold	3,500	–	–	0.04%	156
2018 Q1	$390K	Hold	3,500	–	–	0.03%	165
2017 Q4	$419K	Hold	3,500	–	–	0.03%	171
2017 Q3	$491K	Hold	3,500	–	–	0.04%	158
2017 Q2	$426K	Hold	3,500	–	–	0.04%	160
2017 Q1	$424K	Hold	3,500	–	–	0.03%	164
2016 Q4	$428K	Hold	3,500	–	–	0.03%	163
2016 Q3	$429K	Hold	3,500	–	–	0.04%	160
2016 Q2	$409K	Hold	3,500	–	–	0.04%	153
2016 Q1	$488K	Hold	3,500	–	–	0.04%	132
2015 Q4	$625K	Hold	3,500	–	–	0.05%	122
2015 Q3	$547K	Buy	3,500 +2,867	+453%	+$448K	0.05%	119
2015 Q2	$3.5K	Sell	633 -3,367	-84%	-$18.6K	0.01%	170
2015 Q1	$693K	Hold	4,000	–	–	0.05%	126
2014 Q4	$740K	Hold	4,000	–	–	0.06%	110
2014 Q3	$663K	Hold	4,000	–	–	0.04%	121
2014 Q2	$625K	Hold	4,000	–	–	0.04%	116
2014 Q1	$609K	Hold	4,000	–	–	0.04%	126
2013 Q4	$532K	Hold	4,000	–	–	0.03%	140
2013 Q3	$465K	Hold	4,000	–	–	0.03%	135
2013 Q2	$369K	Buy	+4,000	New	+$369K	0.03%	137